Nanocrystal technology, drug delivery and clinical applications

被引:759
作者
Junghanns, Jens-Uwe A. H. [1 ]
Mueller, Rainer H. [1 ]
机构
[1] Free Univ Berlin, Dept Pharmaceut Technol Biotechnol & Qual Managem, D-12169 Berlin, Germany
关键词
drug nanocrystals; pearl milling; high pressure homogenization; nanocrystal; DissoCubes; Nanopure; bioavailability enhancement; saturation solubility; dissolution velocity;
D O I
10.2147/ijn.s595
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Nanotechnology will affect our lives tremendously over the next decade in very different fields, including medicine and pharmacy. Transfer of materials into the nanodimension changes their physical properties which were used in pharmaceutics to develop a new innovative formulation principle for poorly soluble drugs: the drug nanocrystals. The drug nanocrystals do not belong to the future; the first products are already on the market. The industrially relevant production technologies, pearl milling and high pressure homogenization, are reviewed. The physics behind the drug nanocrystals and changes of their physical properties are discussed. The marketed products are presented and the special physical effects of nanocrystals explained which are utilized in each market product. Examples of products in the development pipelines (clinical phases) are presented and the benefits for in vivo administration of drug nanocrystals are summarized in an overview.
引用
收藏
页码:295 / 309
页数:15
相关论文
共 54 条
[1]  
Anger S., 2005, THESIS FREIE U BERLI
[2]  
[Anonymous], J NEW DRUGS
[3]  
[Anonymous], [No title captured]
[4]  
Bhol KC, 2005, J INVEST DERMATOL, V124, pA117
[5]   Topical nanocrystalline silver cream suppresses inflammatory cytokines and induces apoptosis of inflammatory cells in a murine model of allergic contact dermatitis [J].
Bhol, KC ;
Schechter, PJ .
BRITISH JOURNAL OF DERMATOLOGY, 2005, 152 (06) :1235-1242
[6]   Anti-inflammatory effect of topical nanocrystalline silver cream on allergic contact dermatitis in a guinea pig model [J].
Bhol, KC ;
Alroy, J ;
Schechter, PJ .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2004, 29 (03) :282-287
[7]  
BHOL KC, 2004, CLIN INVEST MED, V274, P196
[8]   Production of drug loaded microparticles by the use of supercritical gases with the aerosol solvent extraction system (ASES) process [J].
Bleich, J ;
Muller, BW .
JOURNAL OF MICROENCAPSULATION, 1996, 13 (02) :131-139
[9]  
Bruno JA, 1992, US Patent, Patent No. 5518187
[10]  
BRUNO RP, 1999, EUR J PHARM BIOPHARM, V0056, P00029